TrialJapanese journal of clinical oncology2022

Phase I/II study of streptozocin monotherapy in Japanese patients with unresectable or metastatic gastroenteropancreatic neuroendocrine tumors.

Izumi Komoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.